Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

NASDAQ:SNBR - Nasdaq - US83125X1037 - Common Stock - Currency: USD

10.07  +0.47 (+4.9%)

After market: 10.28 +0.21 (+2.09%)

Fundamental Rating

2

Taking everything into account, SNBR scores 2 out of 10 in our fundamental rating. SNBR was compared to 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of SNBR have multiple concerns. SNBR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SNBR has reported negative net income.
In the past year SNBR has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
Of the past 5 years SNBR 4 years had a positive operating cash flow.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.57%, SNBR is doing worse than 65.83% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.30%, SNBR is in line with its industry, outperforming 51.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SNBR is significantly below the industry average of 13.34%.
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROIC 4.3%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

SNBR has a Operating Margin of 1.66%. This is comparable to the rest of the industry: SNBR outperforms 48.33% of its industry peers.
SNBR's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 60.25%, SNBR belongs to the best of the industry, outperforming 89.17% of the companies in the same industry.
SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.66%
PM (TTM) N/A
GM 60.25%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

SNBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SNBR has been increased compared to 1 year ago.
SNBR has less shares outstanding than it did 5 years ago.
SNBR has a worse debt/assets ratio than last year.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SNBR has an Altman-Z score of 0.26. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.26, SNBR is not doing good in the industry: 77.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACC0.46
WACC9.37%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR has a Current ratio of 0.19. This is amonst the worse of the industry: SNBR underperforms 98.33% of its industry peers.
A Quick Ratio of 0.08 indicates that SNBR may have some problems paying its short term obligations.
With a Quick ratio value of 0.08, SNBR is not doing good in the industry: 98.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.08
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

SNBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
SNBR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.35%.
SNBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%

3.2 Future

SNBR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.85% yearly.
SNBR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.46% yearly.
EPS Next Y45.88%
EPS Next 2Y48.36%
EPS Next 3Y42.53%
EPS Next 5Y36.85%
Revenue Next Year-10.06%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.37%
Revenue Next 5Y0.46%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNBR. In the last year negative earnings were reported.
SNBR is valuated quite expensively with a Price/Forward Earnings ratio of 55.62.
SNBR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SNBR is more expensive than 61.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.30. SNBR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 55.62
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNBR indicates a rather cheap valuation: SNBR is cheaper than 95.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.39
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

SNBR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SNBR's earnings are expected to grow with 42.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.36%
EPS Next 3Y42.53%

More info and screens

0

5. Dividend

5.1 Amount

SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SLEEP NUMBER CORP

NASDAQ:SNBR (6/3/2025, 8:00:02 PM)

After market: 10.28 +0.21 (+2.09%)

10.07

+0.47 (+4.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners90.07%
Inst Owner Change-15.68%
Ins Owners3.64%
Ins Owner Change34.54%
Market Cap228.19M
Analysts50
Price Target8.5 (-15.59%)
Short Float %16.58%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-721.69%
Min EPS beat(2)-1452.29%
Max EPS beat(2)8.9%
EPS beat(4)3
Avg EPS beat(4)-345.92%
Min EPS beat(4)-1452.29%
Max EPS beat(4)41.39%
EPS beat(8)4
Avg EPS beat(8)-162.76%
EPS beat(12)7
Avg EPS beat(12)-69.04%
EPS beat(16)8
Avg EPS beat(16)-59.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.16%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.11%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-6.21%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.35%
Revenue beat(12)3
Avg Revenue beat(12)-2.76%
Revenue beat(16)4
Avg Revenue beat(16)-3.27%
PT rev (1m)-16.67%
PT rev (3m)-41.86%
EPS NQ rev (1m)-22.22%
EPS NQ rev (3m)-251.72%
EPS NY rev (1m)-20.58%
EPS NY rev (3m)-230.46%
Revenue NQ rev (1m)-4.4%
Revenue NQ rev (3m)-12.64%
Revenue NY rev (1m)-2.81%
Revenue NY rev (3m)-11.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 55.62
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 2.39
EPS(TTM)-0.95
EYN/A
EPS(NY)0.18
Fwd EY1.8%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS70.83
BVpS-20.16
TBVpS-23.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROCE -39.51%
ROIC 4.3%
ROICexc 4.32%
ROICexgc 5%
OM 1.66%
PM (TTM) N/A
GM 60.25%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexcg growth 3Y-45.92%
ROICexcg growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score5
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.17
Cap/Depr 29.51%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.08
Altman-Z 0.26
F-Score5
WACC9.37%
ROIC/WACC0.46
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
EPS Next Y45.88%
EPS Next 2Y48.36%
EPS Next 3Y42.53%
EPS Next 5Y36.85%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%
Revenue Next Year-10.06%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.37%
Revenue Next 5Y0.46%
EBIT growth 1Y-7.48%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year253.84%
EBIT Next 3Y61.41%
EBIT Next 5Y51.81%
FCF growth 1Y20.84%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-130.66%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%